Reversal of BCAA-driven inflammatory senescence by traditional herbal oil prevents atopic dermatitis relapse
- Phytomedicine. 2025 Oct 20:148:157425. doi: 10.1016/j.phymed.2025.157425.
- 1. Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
- 2. Department of pharmacy Research, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China.
- 3. Department of TCM, Kong Jiang Hospital of Yangpu District, Shanghai, 200093, China.
- 4. Department of Dermatology, Seventh people's Hospital of Shanghai University of TCM, Shanghai 200437, China.
- 5. Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China. Electronic address: [email protected].
- 6. Department of pharmacy Research, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China. Electronic address: [email protected].
- 7. Department of Dermatology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China. Electronic address: [email protected].
Background: Atopic dermatitis (AD) is a chronic, relapsing inflammatory skin disease for which effective strategies for achieving sustained remission are lacking. Here, we investigated the efficacy and mechanisms of Liuweirunfu (LWRF) Oil, a traditional Chinese herbal formulation, in preventing AD relapse.
Results: A randomized, controlled clinical trial demonstrated that topical LWRF Oil significantly reduced relapse rates and improved clinical outcomes in AD patients during remission (Chictr.org.cn registration number: ChiCTR2400084762). Metabolomic analysis revealed that LWRF Oil restored the skin metabolome by modulating branched-chain amino acid (BCAA) metabolism. Mechanistically, LWRF Oil reversed inflammatory senescence in a murine AD model by selectively enhancing BCAT1-mediated BCAA catabolism, leading to reduced expression of the senescence marker P21. Furthermore, LWRF Oil modulated Th2 cell responses, dampening their infiltration and activation in the skin.
Conclusions: Our findings indicate that LWRF Oil prevents AD relapse by restoring the skin metabolome, reversing BCAA-driven inflammatory senescence, and modulating Th2 cell responses, suggesting it is a safe and effective approach for long-term AD management.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
target: VD/VDR